Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
243 USD -0.67% Intraday chart for Cencora, Inc. +0.27% +18.31%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Walgreens Lowers Top End of Fiscal 2024 Earnings Outlook Following Second-Quarter Beat MT
Walgreens Boots: reduction in annual targets CF
Cencora Insider Sold Shares Worth $2,583,459, According to a Recent SEC Filing MT
Cencora Insider Sold Shares Worth $1,661,363, According to a Recent SEC Filing MT
Cencora, Inc. Reaffirms Guidance for Year 2024 CI
Transcript : Cencora, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:30 AM
Cencora Says Steven Collis to Retire as CEO; COO Robert Mauch Named Successor; Guidance Affirmed MT
Cencora, Inc. Announces Board Changes, Effective October 1, 2024 CI
Cencora, Inc. Announces CEO Changes, Effective October 1, 2024 CI
Cencora discloses data breach in cybersecurity incident RE
Cencora says hit by cyber attack on its information systems RE
Leerink Partners Starts Coverage on Cencora With Outperform Rating, $261 Price Target MT
This time it's for real Our Logo
ANALYST RECOMMENDATIONS : Lululemon, Nvidia, PayPal, Spotify, Uber... Our Logo
Global markets live: Kering, Publicis, Paypal, Mattel, Nvidia... Our Logo
Walgreens Names Manmohan Mahajan Permanent CFO; Sells Cencora Common Shares MT
Beyond 5,000 Our Logo
Cencora?s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products CI
Walgreens Boots pockets $992 mln after cutting Cencora stake for third time RE
Cencora, Inc. Completes Sale of $500,000,000 Aggregate Principal Amount of its 5.125% Senior Notes Due 2034 CI
Cencora Closes Public Offering of $500 Million Senior Notes MT
Cencora Prices $500 Million Notes Offering MT
UBS Adjusts CoreSite Realty Price Target to $267 From $251, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : AMD, Alphabet, Qualcomm, Mastercard, BP... Our Logo
Tranche Update on Cencora, Inc.'s Equity Buyback Plan announced on May 2, 2023. CI
Chart Cencora, Inc.
More charts
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
243 USD
Average target price
247.8 USD
Spread / Average Target
+1.99%
Consensus
  1. Stock
  2. Equities
  3. Stock Cencora, Inc. - Nyse
  4. News Cencora, Inc.
  5. Health Care Stocks Rising This Afternoon